Publikation
- Metastatic Esophagogastric Adenocarcinoma: Trends in First-Line Treatment and Predictive Factors for the Implementation of HER2 Testing in Clinical Practice During the First Year after Trastuzumab Market ApprovalDeniz Gencer, Salah-Eddin Al-Batran, Reyad Dada, Ali-Nuri Hünerlitürkoglu,,Michael Gonnermann, Thomas Kegel, Harald Scheiber, Wolf-Oliver Jordan, Iris Burkholder, Lenka Kellermann, Ralf-Dieter Hofheinz.Journal of Cancer Res Clin Oncol. 2013 Feb;139(2):337-45 --> Link